Serina Therapeutics (SER) EBT (QoQ) (2018 - 2025)
Serina Therapeutics (SER) EBT (QoQ) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Serina Therapeutics | 43.44 Mn | 20.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.58% |
| Sep 30, 2025 | -7.72% |
| Jun 30, 2025 | 5.33% |
| Mar 31, 2025 | -6.46% |
| Dec 31, 2024 | -8.84% |
| Sep 30, 2024 | -21.13% |
| Jun 30, 2024 | -49.20% |
| Mar 31, 2024 | -790.57% |
| Dec 31, 2023 | 127.83% |
| Sep 30, 2023 | -48.43% |
| Jun 30, 2023 | -0.48% |
| Mar 31, 2023 | 41.19% |
| Dec 31, 2022 | 26.85% |
| Sep 30, 2022 | 6.95% |
| Jun 30, 2022 | 3.29% |
| Mar 31, 2022 | -19.67% |
| Dec 31, 2021 | -15.70% |
| Sep 30, 2021 | 21.01% |
| Jun 30, 2021 | -24.18% |
| Mar 31, 2021 | -45.58% |